Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: A meta-analysis

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Gong, Li Li ^a   Peng, Jian Hao ^b   Han, Fei Fei ^a   Zhu, Jin ^a   Fang, Lian Hua ^c   Wang, Yue Hua ^c   Du, Guan Hua ^c   Wang, He Yao ^a   Liu, Li Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b LERNER RESEARCH INSTITUTE   (United States)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Meta analysis; Myocardial infarction; Plasminogen activator inhibitor 1; Polymorphism; Ttissue plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AFRICAN AMERICAN; AGE; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FEMALE; GENDER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLISHING;

AGE DISTRIBUTION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN INACTIVATORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84865272614     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.015     Document Type: Article

References (60)

1. P. Anversa, and E.H. Sonnenblick Ischemic cardiomyopathy: pathophysiologic mechanisms Prog Cardiovasc Dis 33 1990 49 70
2. J.G. van der Bom, P. de Knijff, F. Haverkate, M.L. Bots, P. Meijer, and P.T. de Jong Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study Circulation 95 1997 2623 2627
3. T.F. Ashavaid, S.P. Todur, A.A. Kondkar, K.G. Nair, K.K. Shalia, and J.J. Dalal Platelet polymorphisms: frequency distribution and association with coronary artery disease in an Indian population Platelets 22 2011 85 91
4. P.M. Ridker, C.H. Hennekens, K. Lindpaintner, M.J. Stampfer, and J.P. Miletich Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men Circulation 95 1997 59 62
5. L. Iacoviello, A. Di Castelnuovo, P. De Knijff, A. D'Orazio, C. Amore, and C. Kluft Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI) Fibrinolysis Proteolysis 10 1996 13 16
6. R. Steeds, M. Adams, P. Smith, K. Channer, and N.J. Samani Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects Thromb Haemost 79 1998 980 984
7. W.C. Hooper, C. Lally, H. Austin, M. Renshaw, A. Dilley, and N.K. Wenger The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism Thromb Res 99 2000 223 230
8. W. Ahmed, M. Malik, I. Saeed, A.A. Khan, A. Sadeque, and U. Kaleem Role of tissue plasminogen activator and plasminogen activator inhibitor polymorphism in myocardial infarction Mol Biol Rep 38 2011 2541 2548
9. E. Falk Stable versus unstable atherosclerosis: clinical aspects Am Heart J 138 1999 S421 S425
10. S. Kathiresan, S.B. Gabriel, Q. Yang, A.L. Lochner, M.G. Larson, and D. Levy Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels Circulation 112 2005 1728 1735
11. S. Dawson, A. Hamsten, B. Wiman, A. Henney, and S. Humphries Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity Arterioscler Thromb 11 1991 183 190
12. S.M. Boekholdt, N.R. Bijsterveld, A.H. Moons, M. Levi, H.R. Buller, and R.J. Peters Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review Circulation 104 2001 3063 3068
13. N. Abboud, L. Ghazouani, S. Saidi, S. Ben-Hadj-Khalifa, F. Addad, and W.Y. Almawi Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study Genet Test Mol Biomarkers 14 2010 23 27
14. P. Eriksson, B. Kallin, F.M. van 't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 1995 1851 1855
15. N. Ossei-Gerning, M.W. Mansfield, M.H. Stickland, I.J. Wilson, and P.J. Grant Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography Arterioscler Thromb Vasc Biol 17 1997 33 37
16. L. Iacoviello, F. Burzotta, A. Di Castelnuovo, F. Zito, R. Marchioli, and M.B. Donati The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis Thromb Haemost 80 1998 1029 1030
17. W. Koch, M. Schrempf, A. Erl, J.C. Mueller, P. Hoppmann, and A. Schomig 4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries Thromb Haemost 103 2010 1170 1180
18. Z. Ye, E.H. Liu, J.P. Higgins, B.D. Keavney, G.D. Lowe, and R. Collins Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls Lancet 367 2006 651 658
19. I. Isordia-Salas, A. Leanos-Miranda, I.M. Sainz, E. Reyes-Maldonado, and G. Borrayo-Sanchez Association of the plasminogen activator inhibitor-1 gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients Rev Esp Cardiol 62 2009 365 372
20. L.S. Rallidis, A. Gialeraki, E. Merkouri, G. Liakos, N. Dagres, and D. Sionis Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction J Thromb Thrombolysis 29 2010 497 502
21. X.-L. Cao, ZC-Y, L. Yin, S.-C. Wang, X.-L. Jia, and H. Huang Reactive protein, plasminogen activator inhibitor type-1 (PAI-1) levels, PAI-1 promoter 4G/5G polymorphism and acute myocardial infarction J Geriatr Cardiol 7 2010 147 151
22. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 [W64]
23. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, and D. Rennie Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
24. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
25. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
26. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
27. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
28. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
29. S.J. Dawson, B. Wiman, A. Hamsten, F. Green, S. Humphries, and A.M. Henney The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells J Biol Chem 268 1993 10739 10745
30. S. Ye, F.R. Green, P.Y. Scarabin, V. Nicaud, L. Bara, and S.J. Dawson The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde Thromb Haemost 74 1995 837 841
31. F. Burzotta, A. Di Castelnuovo, C. Amore, A. D'Orazio, M.B. Donati, and L. Iacoviello 4G/5G polymorphism in the promoter region of the PAI-1 gene is not a risk factor for familial myocardial infarction in subjects over 45 years Thromb Haemost 78 1997 1294 1295
32. N. Iwai, H. Shimoike, Y. Nakamura, S. Tamaki, and M. Kinoshita The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes Atherosclerosis 136 1998 109 114
33. R. Junker, J. Heinrich, H. Schulte, M. Tataru, E. Kohler, and R. Schonfeld Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men Blood Coagul Fibrinolysis 9 1998 597 602
34. H.P. Kohler, M.H. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola, and P.J. Grant Association of a common polymorphism in the factor XIII gene with myocardial infarction Thromb Haemost 79 1998 8 13
35. T. Pastinen, M. Perola, P. Niini, J. Terwilliger, V. Salomaa, and E. Vartiainen Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population Hum Mol Genet 7 1998 1453 1462
36. T. Sugano, H. Tsuji, H. Masuda, K. Nakagawa, H. Nishimura, and T. Kasahara Plasminogen activator inhibitor-1 promoter 4G/5G genotype is not a risk factor for myocardial infarction in a Japanese population Blood Coagul Fibrinolysis 9 1998 201 204
37. J.L. Anderson, J.B. Muhlestein, J. Habashi, J.F. Carlquist, T.L. Bair, and S.P. Elmer Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction J Am Coll Cardiol 34 1999 1778 1783
38. D. Ardissino, P.M. Mannucci, P.A. Merlini, F. Duca, R. Fetiveau, and L. Tagliabue Prothrombotic genetic risk factors in young survivors of myocardial infarction Blood 94 1999 46 51
39. C.J. Doggen, R.M. Bertina, V.M. Cats, P.H. Reitsma, and F.R. Rosendaal The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction Thromb Haemost 82 1999 115 120
40. A. Gardemann, J. Lohre, N. Katz, H. Tillmanns, F.W. Hehrlein, and W. Haberbosch The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease Thromb Haemost 82 1999 1121 1126
41. I. Canavy, M. Henry, P.E. Morange, L. Tiret, O. Poirier, and A. Ebagosti Genetic polymorphisms and coronary artery disease in the south of France Thromb Haemost 83 2000 212 216
42. J. Mikkelsson, M. Perola, U. Wartiovaara, L. Peltonen, A. Palotie, and A. Penttila Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly Thromb Haemost 84 2000 78 82
43. J. Song, Y.M. Yoon, H.J. Jung, S.H. Hong, H. Park, and J.Q. Kim Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353->Gln polymorphism in Korean patients with coronary artery disease J Korean Med Sci 15 2000 146 152
44. L. Fu, H. Jin, K. Song, C. Zhang, J. Shen, and Y. Huang Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction Chin Med J (Engl) 114 2001 266 269
45. L.A. Hindorff, S.M. Schwartz, D.S. Siscovick, B.M. Psaty, W.T. Longstreth Jr., and A.P. Reiner The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women J Cardiovasc Risk 9 2002 131 137
46. Y. Yamada, H. Izawa, S. Ichihara, F. Takatsu, H. Ishihara, and H. Hirayama Prediction of the risk of myocardial infarction from polymorphisms in candidate genes N Engl J Med 347 2002 1916 1923
47. P. Crainich, N.S. Jenny, Z. Tang, A.M. Arnold, L.H. Kuller, and T. Manolio Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly J Thromb Haemost 1 2003 1799 1804
48. I. Juhan-Vague, P.E. Morange, C. Frere, M.F. Aillaud, M.C. Alessi, and E. Hawe The plasminogen activator inhibitor-1-675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study J Thromb Haemost 1 2003 2322 2329
49. K. Leander, B. Wiman, J. Hallqvist, M. Sten-Linder, and U. de Faire PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP) Thromb Haemost 89 2003 1064 1071
50. [MPA] P.M. Mannucci, D. Ardissino, C. Barzuini, F. Bernardi, L. Bernardinelli, and C. Cavallini No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age Circulation 107 2003 1117 1122
51. D. Petrovic, M. Globocnik-Petrovic, and B. Peterlin 4G4G genotype of PAI-1 gene promoter polymorphism is not associated with myocardial infarction in Caucasians with type-2 diabetes Cardiology 100 2003 157 158
52. M. Zhan, Y. Zhou, and Z. Han Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China Chin Med J (Engl) 116 2003 1707 1710
53. M.D. Tobin, P.S. Braund, P.R. Burton, J.R. Thompson, R. Steeds, and K. Channer Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study Eur Heart J 25 2004 459 467
54. K. Jood, P. Ladenvall, A. Tjarnlund-Wolf, C. Ladenvall, M. Andersson, and S. Nilsson Fibrinolytic gene polymorphism and ischemic stroke Stroke 36 2005 2077 2081
55. C.H. Martini, C.J. Doggen, C. Cavallini, F.R. Rosendaal, and P.M. Mannucci No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors J Thromb Haemost 3 2005 177 179
56. R.J. Pegoraro, and N. Ranjith Plasminogen activator inhibitor type 1 (PAI-1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in young Asian Indians with acute myocardial infarction Cardiovasc J S Afr 16 2005 266 270
57. P.E. Morange, N. Saut, M.C. Alessi, J.S. Yudkin, M. Margaglione, and G. Di Minno Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study Arterioscler Thromb Vasc Biol 27 2007 2250 2257
58. M.F. Sampaio, M.H. Hirata, R.D. Hirata, F.C. Santos, R. Picciotti, and A.D. Luchessi AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults Clin Chim Acta 377 2007 154 162
59. O. Onalan, G. Balta, A. Oto, G. Kabakci, L. Tokgozoglu, and K. Aytemir Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease J Thromb Thrombolysis 26 2008 211 217
60. H.P. Kohler, and P.J. Grant Plasminogen-activator inhibitor type 1 and coronary artery disease N Engl J Med 342 2000 1792 1801